EFFICACY AND SAFETY OF ADALIMUMAB VERSUS INFLIXIMAB IN PATIENTS SUFFERED FROM MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS

Authors

  • Article Retracted college of pharmacy university of mustansiriyah

Abstract

Article Retracted

Downloads

Download data is not yet available.

Author Biography

Article Retracted, college of pharmacy university of mustansiriyah

pharmacology

References

Article Retracted

Published

01-03-2017

How to Cite

Retracted, A. “EFFICACY AND SAFETY OF ADALIMUMAB VERSUS INFLIXIMAB IN PATIENTS SUFFERED FROM MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 10, no. 3, Mar. 2017, pp. 300-7, https://journals.innovareacademics.in/index.php/ajpcr/article/view/16213.

Issue

Vol 10 Issue 3 March 2017

Section

Original Article(s)

The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.